Study of an experimental drug in healthy adults
Treatments studied
Part of Immune system & allergy, Kidney & urinary, Women’s health & pregnancy clinical trials.
This Phase 1 trial tests how safe and tolerable an experimental medicine (HS-10390) is in healthy adults, and how the body processes it. It is not for people with an illness, but for healthy volunteers to help researchers understand the drug before future studies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 to 45 years old
- Be healthy overall, with no major medical problems affecting safety or drug processing
- For people who could get pregnant: use a highly effective birth-control method, and do not donate eggs or sperm during the study and for at least 6 months after the last dose
- Have no recent infections (including tuberculosis) and have negative screening tests for certain infections like hepatitis, HIV/AIDS, and syphilis
- Not have a history of significant allergies
- Not smoke heavily (at least 5 cigarettes/day in the past 3 months) and pass nicotine testing
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new investigational drug called ISH0613 in healthy volunteers to see if it is safe and how the body processes it. It is the first time this drug is given to humans.
This early-stage study tests how a new experimental medication (HSK55879) is tolerated and processed by the body in healthy volunteers. Researchers will also check how food affects the drug's absorption to help determine safe dosing for future patient studies.
This trial tests a new drug called SNH-119014 for the first time in humans. It involves healthy volunteers to check the drug's safety and how the body processes it. It may be a step toward a new treatment for certain conditions.
This trial tests a new medicine called HS-10390 to see if it can help people with IgA nephropathy, a kidney disease. It aims to reduce protein in the urine and protect kidney function.
This trial tests a new medicine called HS-10542 for people with IgA nephropathy, a kidney disease. It aims to see if the drug is safe and helps reduce protein in the urine, which is a sign of kidney damage.
This study tests a new medicine called HS-10390 to see if it can help people with chronic kidney disease. It might slow down the disease and protect your kidneys.
Hear when a new IgA Nephropathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.